.webp?width=217&height=60&name=Screenpoint-Med%20(1).webp "Screen Point Medical")
MASAI RCT: 12% reduction in interval cancer rate using Transpara
%20(1).png)
MASAI RCT: 12% reduction in interval cancer rate using Transpara
Transpara® Breast AI Selected for $16M PRISM Randomized Controlled Trial in USA
.png)
Transpara® Breast AI Selected for $16M PRISM Randomized Controlled Trial in USA
ScreenPoint Medical Enables Transpara® Breast AI within Precision Imaging Network, part of Microsoft for Healthcare
.png)
ScreenPoint Medical Enables Transpara® Breast AI within Precision Imaging Network, part of Microsoft for Healthcare
ScreenPoint Medical Deploys Transpara® Breast AI at Johns Hopkins to Improve Cancer Detection
.png)
ScreenPoint Medical Deploys Transpara® Breast AI at Johns Hopkins to Improve Cancer Detection
Transpara implemented for clinical use by key thought leaders in radiology and breast imaging.
March 12, 2024
ScreenPoint Medical Showcases Transpara® Breast AI Designed to Improve Cancer Detection and Support Single Reader Screening at ECR
.png)
ScreenPoint Medical Showcases Transpara® Breast AI Designed to Improve Cancer Detection and Support Single Reader Screening at ECR
AI-Supported Screening Delivering Real-World Clinical Results in Research Studies being Presented at ECR
February 21, 2024